citrus/抗真菌薬

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to regimens and therapeutics intended to inhibit the formation, progression and metastatic conversion of a variety of cancers in mammals, including humans. Cancers effectively targeted by this regimen include solid

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to bio-affecting and body treating compositions. More particularly, this invention relates to a therapeutic composition or balm consisting of specific essential oils. 2. Description of the Related Art For thousands of

FIELD OF THE INVENTION The present invention is directed to a process for inhibiting the growth of fungus microorganisms and to an antifungal composition. The invention is further directed to an antifungal composition containing a mixture of plant materials that is effective in inhibiting the growth

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a methoxyacrylate, the preparation, fungicides containing same, and the use as a fungicide 2. Description of the Related Art The methoxyacrylate fungicides were firstly developed by Zeneca Co., Ltd. (Syngenta) in 1980s

This invention relates to silica-based nanoformulations, and in particular to, compositions and methods for fabricating silica-based nanoparticles and silica-based nanogels, or a combination thereof, that provide a unique nanoenvironment to host antibacterial and antifungal agents, method of

FIELD OF THE INVENTION The present application relates to a method for identifying target regions existing in the interface of monomers constituting the PilT protein with a view to design molecules that are potentially applicable in impairing the activity of this protein, thus controlling infectious

FIELD OF THE INVENTION The present disclosure relates to compositions comprising cannabinoids and melatonin, and formulations and products suitable for administering effective doses of the compositions to a subject. BACKGROUND OF THE INVENTION Cannabis, commonly known as marijuana, hemp, and by

FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and

FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and

FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor. BACKGROUND OF THE INVENTION Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica

BACKGROUND Lactobacillus delbrueckii subsp bulgaricus (LBD) is a gram-positive homofermentative lactic acid bacteria which metabolizes carbohydrates with lactic acid as the major end product (Salminen, S., and von Wright, A., "Current Probiotics-Safety Assured?" Microbial Ecology in Health and

BACKGROUND Lactobacillus delbrueckii subsp bulgaricus (LBD) is a gram-positive homofermentative lactic acid bacteria which metabolizes carbohydrates with lactic acid as the major end product (Salminen, S., and von Wright, A., "Current Probiotics-Safety Assured?" Microbial Ecology in Health and

FIELD OF THE INVENTION The embodiments of the present invention relate to the delivery of cannabinoids via lozenge or troche. BACKGROUND Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and as medicine.

FIELD OF THE INVENTION The embodiments of the present invention relate to the delivery of cannabinoids via lozenge or troche. BACKGROUND Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and as medicine.

BACKGROUND OF THE INVENTION Field of the Invention This invention relates to antiseptic compositions and, more particularly, to a nasal antiseptic barrier composition having antimicrobial, antiviral, and antifungal properties. Discussion of the Related Art In recent years, outbreaks of new and